MedPath

A randomized controlled trial of acupuncture in the treatment of ovarian reserve dysfunctio

Phase 1
Not yet recruiting
Conditions
ovarian reserve dysfunction
Registration Number
ITMCTR2200005907
Lead Sponsor
Chengdu Xinan gynecological hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) 20 years = age < 40 years;

(2) Meet the diagnostic criteria of ovarian reserve dysfunction;

(3) Voluntarily participate in the trial and sign the informed consent form.

Exclusion Criteria

(1) Patients suffering from severe systemic organic diseases such as heart, liver and kidney, which makes it difficult to achieve pregnancy;

(2) Combined with congenital reproductive organ development abnormalities affecting pregnancy, endometrial polyps, hysteromyomas, endometriosis, or other organic diseases.

(3) Patients with polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, hypothyroidism, chronic adrenocortical dysfunction and other diseases;

(4) Severe wasting disease or developing malignant tumor;

(5) Patients with bleeding tendency and prone to infection, or patients with severe allergies, or patients with skin ulcers, scars and other prohibited acupuncture;

(6) IVF-ET planners are expected within 2 months after enrollment.

Note: patients who meet any of the above conditions should be excluded.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.